Liv.52 DS

Chicory, The Caper Bush

Directions for Use:

Please consult your physician to prescribe the dosage that best suits the condition.

Indications:

• Symptomatic improvement and supportive treatment of early and mild to moderate:
-Viral hepatitis
-Alcoholic liver disease
-Non-alcoholic fatty liver disease (NAFLD)
-Drug induced liver injury (DILI)
• Anorexia/Loss of appetite
• Symptomatic improvement of anorexia and jaundice during pregnancy
• Symptomatic improvement and supportive treatment of liver injury due to chemotherapy and radiotherapy
• As an adjuvant to hepatotoxic drugs like anti-tubercular drugs, statins, and antiretrovirals.

Side Effects:

Liv.52 is not known to have any significant adverse reaction or serious adverse event if taken as per the prescribed dosage.

Note: The information on this page is not intended to be a substitute for professional medical advice. Do not use this information to diagnose or treat your problem without consulting your doctor.

Liv.52 was launched in 1955, and physicians worldwide recommend Liv.52 (tablet, syrup, and drops forms), for various hepatic disorders. Liv.52 is an extensively researched product of Himalaya Wellness Company. The potential hepatoprotective effect of Liv.52 has been established through numerous clinical studies, including randomized double blind, placebo controlled, open label studies, as well as independent investigator initiated clinical studies across many countries. The product has numerous research articles published in national and international scientific journals. Overall, the results derived from these research articles suggest that Liv.52 is beneficial for supportive treatment in improving the symptoms, hepatic parameters, and quality of life in a wide variety of liver diseases like drug-induced hepatotoxicity, hepatitis, alcoholic liver disease, and non-alcoholic fatty liver disease.

Each herbal ingredient of Liv.52 is analyzed as per the standards set by Pharmacopoeia (IP, BP, EP, and USP)*. A battery of non-clinical toxicological studies (acute, subacute, chronic, genotoxicity, developmental, and reproductive toxicity studies) have further reinforced the safety of Liv.52, with a wide margin of safety. Himalaya Wellness Company's advanced Research and Development (R&D) Center is certified for Good Laboratory Practices (GLP) for following international Organization for Economic Co-operation and Development (OECD) guidelines.

We ensure consistent quality in every batch (as per WHO standards for herbal medicines). Himalaya's manufacturing facility is GMP certified and audited at regular intervals by the Ministry of Health (MOH) and regulatory bodies of several countries.

Considering some trace levels of heavy metals occurring naturally in botanical/plants/food ingredients, many regulatory bodies have defined the permissible limits for heavy metal contaminants in herbal medicines after considering the geographical aspects of such contaminants. In this direction, both WHO and AYUSH have defined the limits of heavy metals (lead, cadmium, arsenic, and mercury) in herbal medicines. We, at Himalaya Wellness Company, follow these guidelines for all our medicinal products and ensure that our products comply with these regulations.

* IP: Indian Pharmacopoeia
BP: British Pharmacopoeia
EP: European Pharmacopoeia
USP: United States Pharmacopoeia

Product Type: Tablet

Country of Origin: India

Manufactured by: Himalaya Wellness Company, Makali, Bangalore - 562162, Karnataka, India

For Queries, Contact: Manager - Customer Care, Himalaya Wellness Company, Makali, Bengaluru - 562162, Karnataka, India
Email: contactus@himalayawellness.com
Call 1-800-208-1930 (Toll-free in India)
www.himalayawellness.in